A new animal health company, EmGenisys, has created what it describes as the first non-invasive and objective method to evaluate a bovine embryo’s health to improve the success rates of embryo transfer and in vitro fertilization.
“We are scanning embryos and using software to provide veterinarians and IVF enterprises with more objective data regarding an embryo’s developmental stress, metabolic function and overall health,” says Cara Wells, founder and CEO.
The company has developed a web-based platform, EmGenuity, which hosts an advanced analytics and machine learning assessment called EmVision.
By RHONDA BROOKS
July 17, 2023
bovinevetonline.com
Comments